Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2010, Article ID 214745, 5 pages
Review Article

The Influence of Pregnancy on the Recurrence of Cutaneous Malignant Melanoma in Women

1Department of Metabolic and Endocrine Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3584 EA Utrecht, The Netherlands
2Department of General Practice, University Medical Centre Utrecht, 3732 HJ De Bilt, The Netherlands
3Department of Surgical Oncology, VU University Medical Centre, 1081 HV Amsterdam, The Netherlands

Received 25 May 2010; Accepted 24 June 2010

Academic Editor: Ashfaq A. Marghoob

Copyright © 2010 M. Albersen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Netherlands Cancer Registry, “Incidence of Cancer in the Netherlands”.
  2. M. S. Driscoll and J. M. Grant-Kels, “Hormones, nevi, and melanoma: an approach to the patient,” Journal of the American Academy of Dermatology, vol. 57, no. 6, pp. 919–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. T. Pack and I. M. Scharnagel, “The Prognosis for Malignant Melanoma in the Pregnant Woman,” Cancer, vol. 4, pp. 324–334, 1951. View at Google Scholar
  4. B. F. Byrd Jr. and W. J. McGanity, “The effect of pregnancy on the clinical course of malignant melanoma,” Southern medical journal, vol. 47, no. 3, pp. 196–200, 1954. View at Google Scholar
  5. J. H. F. Shaw, “Malignant melanoma in Auckland, New Zealand,” Surgery Gynecology and Obstetrics, vol. 166, no. 5, pp. 425–430, 1988. View at Google Scholar · View at Scopus
  6. K. Bork, W. Brauninger, and B. M. Czarnetzki, “Schwangerschaft nach Malignem Melanom: Verlaufsbeobachtung bei 23 Patientinnen,” Deutsche Medizinische Wochenschrift, vol. 110, no. 35, pp. 1323–1327, 1985. View at Google Scholar · View at Scopus
  7. S. Retsas and M. J. Mastrangelo, “Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma,” Seminars in Oncology, vol. 34, no. 6, pp. 491–497, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Offringa, W. J. J. Assendelft, and R. J. P. M. Scholten, Inleiding in evidence-based medicine: klinisch handelen gebaseerd op bewijsmateriaal, Bohn Stafleu van Loghum, Houten, The Netherlands, 2nd edition, 2003.
  9. D. S. Reintgen, K. S. McCarthy Jr., and R. Vollmer, “Malignant melanoma and pregnancy,” Cancer, vol. 55, no. 6, pp. 1340–1344, 1985. View at Google Scholar · View at Scopus
  10. R. M. MacKie, R. Bufalino, A. Morabito, C. Sutherland, and N. Cascinelli, “Lack of effect of pregnancy on outcome of melanoma,” Lancet, vol. 337, no. 8742, pp. 653–655, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. W.-J. Poo-Hwu, S. Ariyan, L. Lamb et al., “Follow-up recommendations for patients with American Joint Committee on cancer stages I-III malignant melanoma,” Cancer, vol. 86, no. 11, pp. 2252–2258, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. T. R. Fincher, T. M. McCarty, T. L. Fisher et al., “Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma,” American Journal of Surgery, vol. 186, no. 6, pp. 675–681, 2003. View at Publisher · View at Google Scholar · View at Scopus